(ASML) ASML Holding - Overview
Exchange: NASDAQ •
Country: Netherlands •
Currency: USD •
Type: Common Stock •
ISIN: USN070592100
Stock:
Total Rating 73
Risk 86
Buy Signal 0.09
| Risk 5d forecast | |
|---|---|
| Volatility | 41.0% |
| Relative Tail Risk | -6.92% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.92 |
| Alpha | 72.54 |
| Character TTM | |
|---|---|
| Beta | 1.524 |
| Beta Downside | 1.856 |
| Drawdowns 3y | |
|---|---|
| Max DD | 45.48% |
| CAGR/Max DD | 0.73 |
EPS (Earnings per Share)
Revenue
Description: ASML ASML Holding
ASML Holding N.V. provides lithography solutions for the development, production, marketing, sales, upgrading, and servicing of advanced semiconductor equipment systems. It offers lithography, metrology, and inspection systems. The company also provides extreme ultraviolet lithography systems; and deep ultraviolet lithography systems comprising immersion and dry lithography systems solutions to manufacture various range of semiconductor nodes and technologies. In addition, it offers metrology and inspection systems, including YieldStar optical metrology systems to assess the quality of patterns on the wafers; and HMI electron beam solutions to identify and analyze individual chip defects. Further, the company provides computational lithography solutions, and lithography systems and control software solutions; and refurbishes and upgrades lithography systems, as well as offers customer support and related services. Additionally, it offers hardware, software, and services to chipmakers to produce the patterns of integrated circuits. The company operates in Japan, South Korea, Singapore, Taiwan, China, rest of Asia, the Netherlands, rest of Europe, the Middle East, Africa, and the United States. The company was formerly known as ASM Lithography Holding N.V. and changed its name to ASML Holding N.V. in 2001. ASML Holding N.V. was founded in 1984 and is headquartered in Veldhoven, the Netherlands.
Piotroski VR‑10 (Strict, 0-10) 9.0
| Net Income: 9.97b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.21 > 0.02 and ΔFCF/TA 1.63 > 1.0 |
| NWC/Revenue: 19.49% < 20% (prev 37.81%; Δ -18.32% < -1%) |
| CFO/TA 0.25 > 3% & CFO 12.86b > Net Income 9.97b |
| Net Debt (-10.20b) to EBITDA (13.15b): -0.78 < 3 |
| Current Ratio: 1.26 > 1.5 & < 3 |
| Outstanding Shares: last quarter (388.9m) vs 12m ago -1.19% < -2% |
| Gross Margin: 52.57% > 18% (prev 0.51%; Δ 5206 % > 0.5%) |
| Asset Turnover: 65.72% > 50% (prev 58.17%; Δ 7.55% > 0%) |
| Interest Coverage Ratio: 101.5 > 6 (EBITDA TTM 13.15b / Interest Expense TTM 118.3m) |
Altman Z'' 4.18
| A: 0.13 (Total Current Assets 30.60b - Total Current Liabilities 24.25b) / Total Assets 50.55b |
| B: 0.35 (Retained Earnings 17.59b / Total Assets 50.55b) |
| C: 0.24 (EBIT TTM 12.00b / Avg Total Assets 49.57b) |
| D: 0.57 (Book Value of Equity 17.59b / Total Liabilities 30.94b) |
| Altman-Z'' Score: 4.18 = AA |
Beneish M -3.24
| DSRI: 0.66 (Receivables 4.16b/5.44b, Revenue 32.58b/28.26b) |
| GMI: 0.98 (GM 52.57% / 51.28%) |
| AQI: 1.06 (AQ_t 0.23 / AQ_t-1 0.22) |
| SGI: 1.15 (Revenue 32.58b / 28.26b) |
| TATA: -0.06 (NI 9.97b - CFO 12.86b) / TA 50.55b) |
| Beneish M-Score: -3.24 (Cap -4..+1) = AA |
What is the price of ASML shares?
As of February 28, 2026, the stock is trading at USD 1450.56 with a total of 1,346,696 shares traded.
Over the past week, the price has changed by -1.29%, over one month by -0.15%, over three months by +37.03% and over the past year by +109.73%.
Over the past week, the price has changed by -1.29%, over one month by -0.15%, over three months by +37.03% and over the past year by +109.73%.
Is ASML a buy, sell or hold?
ASML Holding has received a consensus analysts rating of 4.25.
Therefore, it is recommended to buy ASML.
- StrongBuy: 22
- Buy: 8
- Hold: 9
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the ASML price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 1486.7 | 2.5% |
| Analysts Target Price | 1486.7 | 2.5% |
ASML Fundamental Data Overview February 28, 2026
Market Cap EUR = 481.58b (568.17b USD * 0.8476 USD.EUR)
P/E Trailing = 50.2506
P/E Forward = 34.0136
P/S = 17.3926
P/B = 19.3404
P/EG = 1.9205
Revenue TTM = 32.58b EUR
EBIT TTM = 12.00b EUR
EBITDA TTM = 13.15b EUR
Long Term Debt = 2.71b EUR (from longTermDebt, last quarter)
Short Term Debt = 1.68b EUR (from shortLongTermDebt, last quarter)
Debt = 2.71b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = -10.20b EUR (from netDebt column, last quarter)
Enterprise Value = 470.97b EUR (481.58b + Debt 2.71b - CCE 13.32b)
Interest Coverage Ratio = 101.5 (Ebit TTM 12.00b / Interest Expense TTM 118.3m)
EV/FCF = 43.89x (Enterprise Value 470.97b / FCF TTM 10.73b)
FCF Yield = 2.28% (FCF TTM 10.73b / Enterprise Value 470.97b)
FCF Margin = 32.94% (FCF TTM 10.73b / Revenue TTM 32.58b)
Net Margin = 30.60% (Net Income TTM 9.97b / Revenue TTM 32.58b)
Gross Margin = 52.57% ((Revenue TTM 32.58b - Cost of Revenue TTM 15.45b) / Revenue TTM)
Gross Margin QoQ = 52.16% (prev 51.63%)
Tobins Q-Ratio = 9.32 (Enterprise Value 470.97b / Total Assets 50.55b)
Interest Expense / Debt = 4.37% (Interest Expense 118.3m / Debt 2.71b)
Taxrate = 17.89% (612.9m / 3.43b)
NOPAT = 9.86b (EBIT 12.00b * (1 - 17.89%))
Current Ratio = 1.26 (Total Current Assets 30.60b / Total Current Liabilities 24.25b)
Debt / Equity = 0.14 (Debt 2.71b / totalStockholderEquity, last quarter 19.60b)
Debt / EBITDA = -0.78 (Net Debt -10.20b / EBITDA 13.15b)
Debt / FCF = -0.95 (Net Debt -10.20b / FCF TTM 10.73b)
Total Stockholder Equity = 18.43b (last 4 quarters mean from totalStockholderEquity)
RoA = 20.11% (Net Income 9.97b / Total Assets 50.55b)
RoE = 54.09% (Net Income TTM 9.97b / Total Stockholder Equity 18.43b)
RoCE = 56.79% (EBIT 12.00b / Capital Employed (Equity 18.43b + L.T.Debt 2.71b))
RoIC = 308.2% (NOPAT 9.86b / Invested Capital 3.20b)
WACC = 11.49% (E(481.58b)/V(484.29b) * Re(11.53%) + D(2.71b)/V(484.29b) * Rd(4.37%) * (1-Tc(0.18)))
Discount Rate = 11.53% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.62%
[DCF] Terminal Value 60.18% ; FCFF base≈10.25b ; Y1≈7.78b ; Y5≈4.74b
[DCF] Fair Price = 167.4 (EV 54.79b - Net Debt -10.20b = Equity 64.99b / Shares 388.1m; r=11.49% [WACC]; 5y FCF grow -28.62% → 2.90% )
EPS Correlation: 64.40 | EPS CAGR: 42.60% | SUE: -4.0 | # QB: 0
Revenue Correlation: 76.74 | Revenue CAGR: 30.63% | SUE: -1.47 | # QB: 0
EPS next Quarter (2026-03-31): EPS=6.65 | Chg7d=+0.000 | Chg30d=+0.714 | Revisions Net=+6 | Analysts=14
EPS current Year (2026-12-31): EPS=29.65 | Chg7d=-0.016 | Chg30d=+2.358 | Revisions Net=+27 | Growth EPS=+20.0% | Growth Revenue=+14.4%
EPS next Year (2027-12-31): EPS=37.33 | Chg7d=+0.081 | Chg30d=+3.386 | Revisions Net=+26 | Growth EPS=+25.9% | Growth Revenue=+17.3%
[Analyst] Revisions Ratio: +0.75 (7 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 9.5% (Discount Rate 11.5% - Earnings Yield 2.0%)
[Growth] Growth Spread = +1.6% (Analyst 11.2% - Implied 9.5%)
P/E Trailing = 50.2506
P/E Forward = 34.0136
P/S = 17.3926
P/B = 19.3404
P/EG = 1.9205
Revenue TTM = 32.58b EUR
EBIT TTM = 12.00b EUR
EBITDA TTM = 13.15b EUR
Long Term Debt = 2.71b EUR (from longTermDebt, last quarter)
Short Term Debt = 1.68b EUR (from shortLongTermDebt, last quarter)
Debt = 2.71b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = -10.20b EUR (from netDebt column, last quarter)
Enterprise Value = 470.97b EUR (481.58b + Debt 2.71b - CCE 13.32b)
Interest Coverage Ratio = 101.5 (Ebit TTM 12.00b / Interest Expense TTM 118.3m)
EV/FCF = 43.89x (Enterprise Value 470.97b / FCF TTM 10.73b)
FCF Yield = 2.28% (FCF TTM 10.73b / Enterprise Value 470.97b)
FCF Margin = 32.94% (FCF TTM 10.73b / Revenue TTM 32.58b)
Net Margin = 30.60% (Net Income TTM 9.97b / Revenue TTM 32.58b)
Gross Margin = 52.57% ((Revenue TTM 32.58b - Cost of Revenue TTM 15.45b) / Revenue TTM)
Gross Margin QoQ = 52.16% (prev 51.63%)
Tobins Q-Ratio = 9.32 (Enterprise Value 470.97b / Total Assets 50.55b)
Interest Expense / Debt = 4.37% (Interest Expense 118.3m / Debt 2.71b)
Taxrate = 17.89% (612.9m / 3.43b)
NOPAT = 9.86b (EBIT 12.00b * (1 - 17.89%))
Current Ratio = 1.26 (Total Current Assets 30.60b / Total Current Liabilities 24.25b)
Debt / Equity = 0.14 (Debt 2.71b / totalStockholderEquity, last quarter 19.60b)
Debt / EBITDA = -0.78 (Net Debt -10.20b / EBITDA 13.15b)
Debt / FCF = -0.95 (Net Debt -10.20b / FCF TTM 10.73b)
Total Stockholder Equity = 18.43b (last 4 quarters mean from totalStockholderEquity)
RoA = 20.11% (Net Income 9.97b / Total Assets 50.55b)
RoE = 54.09% (Net Income TTM 9.97b / Total Stockholder Equity 18.43b)
RoCE = 56.79% (EBIT 12.00b / Capital Employed (Equity 18.43b + L.T.Debt 2.71b))
RoIC = 308.2% (NOPAT 9.86b / Invested Capital 3.20b)
WACC = 11.49% (E(481.58b)/V(484.29b) * Re(11.53%) + D(2.71b)/V(484.29b) * Rd(4.37%) * (1-Tc(0.18)))
Discount Rate = 11.53% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.62%
[DCF] Terminal Value 60.18% ; FCFF base≈10.25b ; Y1≈7.78b ; Y5≈4.74b
[DCF] Fair Price = 167.4 (EV 54.79b - Net Debt -10.20b = Equity 64.99b / Shares 388.1m; r=11.49% [WACC]; 5y FCF grow -28.62% → 2.90% )
EPS Correlation: 64.40 | EPS CAGR: 42.60% | SUE: -4.0 | # QB: 0
Revenue Correlation: 76.74 | Revenue CAGR: 30.63% | SUE: -1.47 | # QB: 0
EPS next Quarter (2026-03-31): EPS=6.65 | Chg7d=+0.000 | Chg30d=+0.714 | Revisions Net=+6 | Analysts=14
EPS current Year (2026-12-31): EPS=29.65 | Chg7d=-0.016 | Chg30d=+2.358 | Revisions Net=+27 | Growth EPS=+20.0% | Growth Revenue=+14.4%
EPS next Year (2027-12-31): EPS=37.33 | Chg7d=+0.081 | Chg30d=+3.386 | Revisions Net=+26 | Growth EPS=+25.9% | Growth Revenue=+17.3%
[Analyst] Revisions Ratio: +0.75 (7 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 9.5% (Discount Rate 11.5% - Earnings Yield 2.0%)
[Growth] Growth Spread = +1.6% (Analyst 11.2% - Implied 9.5%)